LifeScience Biologics

China’s NMPA Accepts Clinical Trial Application for Harbour BioMed’s Obesity Antibody LET003

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeut...

 November 20, 2026 | News

Sino Biological Launches Two Target Protein Collections for AI-Driven Discovery

11,000+ Target Proteins. Reliable Supply. Built for AI-Driven Discovery. As AI accelerates recombinant protein and antibody discovery for therapeutic and ...

 November 20, 2026 | News

Cognizant Launches Patient Hub Operations to Shorten the Wait for Therapy

Built on NVIDIA accelerated computing, Cognizant Patient Hub Operations is designed to reduce administrative delays to therapy and let programs take on mor...

 November 20, 2026 | News

Thermo Fisher Scientific Introduces Gibco VaxEvo CD 293 Medium for Adenovirus Vaccine Production

Thermo Fisher Scientific, the world leader in serving science, announced the Gibco™ VaxEvo™ CD 293 Medium, a chemically defined and animal orig...

 November 19, 2026 | News

Harbour BioMed Partner Spruce Forms Adrenyx Biosciences to Advance CRHX-101

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics i...

 November 19, 2026 | News

Lonza Licenses NeuroPortal Blood-Brain Barrier Technology to China Medical System

Lonza grants CMS global rights to newly acquired TfR1 technology in up to two neurodegenerative disease targets.  Lonza’s NeuroPortal...

 November 18, 2026 | News

Delonix Bioworks and A*STAR IDL Collaborate on Vaccines Against Drug-Resistant Klebsiella pneumoniae

Delonix Bioworks, a clinical-stage biotechnology company pioneering next-generation outer membrane vesicle (OMV) vaccines, today announced that it has ente...

 November 18, 2026 | News

China’s NMPA Accepts Akeso’s Ivonescimab Application for First-Line Biliary Tract Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental ...

 November 18, 2026 | News

Eppendorf and Nova Biomedical Integrate Sampling and Analysis to Automate Bioprocess Control

Eppendorf and Nova Biomedical® collaborate to integrate the Eppendorf Bioprocess Autosampler with the BioProfile FLEX2 cell culture analyzer. The integ...

 November 18, 2026 | News

Innovent’s Zybrivo Receives Positive CHMP Opinion for Advanced Lung Cancer

The opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) is Innovent's first European regulatory...

 November 17, 2026 | News

IDEAYA Nominates IDE101 as Development Candidate for CDKN2A-Deficient Solid Tumours

Development candidate demonstrates encouraging preclinical activity in CDKN2A-deficienct tumor models as a monotherapy and in combi...

 November 17, 2026 | News

Eli Radiopharma Raises Nearly RMB 400 Million in Series A to Advance Radiopharmaceutical Pipeline

Hangzhou Eli Radiopharma Co., Ltd. ("Eli Radiopharma", or "the Company"), an innovative radiopharmaceutical company focused on integrated diagnostics and t...

 November 16, 2026 | News

HTL Biotechnology Opens €15 Million Polynucleotide Production Unit in France

HTL Biotechnology, a world leader in the development and production of pharmaceutical-grade biopolymers, inaugurated its new production unit, HTL8, dedicat...

 November 16, 2026 | News

Zai Lab Secures China NRDL Coverage for Five Medicines, Including Two New Listings

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, announced that five of its commercial medicines in China have b...

 November 16, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close